Case Study: Global Biopharma Major Manufacturing Company improves flu vaccine sales and outbreak prediction with CSS Corp analytics

Deep Analytics Strategy and Implementation for a Global Pharma Major

Global Biopharma Major Manufacturing Company, a global biopharma manufacturer serving more than 170 countries, wanted a better way to organize and analyze large volumes of unstructured data to address declining flu vaccine sales, improve customer education, and predict flu outbreaks. CSS Corp supported the company with a deep analytics strategy using Google Cloud Platform, predictive analytics, and data modeling to turn complex health, weather, and customer data into actionable insights.

CSS Corp implemented a reusable analytics framework that combined simulation modeling, social media analytics, machine learning, and real-time dashboards to forecast flu outbreaks up to three weeks in advance, identify factors affecting vaccine adoption, and target interventions more effectively. The solution improved sales governance, enabled faster data-to-insight cycles, increased understanding of patient perceptions, and helped drive better vaccine acceptance and sales performance.